Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Cancer remains one of the most formidable challenges in modern medicine, due to its complex and dynamic nature, which demands innovative therapeutic approaches. One major challenge to cancer treatment is the tumour microenvironment and in particular tumour hypoxia (low oxygen levels), which contribu...
Saved in:
Main Author: | Brian M Ortmann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Oncology |
Online Access: | https://bmjoncology.bmj.com/content/3/1/e000154.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer Management
by: Laura M. S. Seeber, et al.
Published: (2010-01-01) -
Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?
by: Hemant Kumar, et al.
Published: (2015-01-01) -
Inflammation and Immune Escape in Ovarian Cancer: Pathways and Therapeutic Opportunities
by: Liu C, et al.
Published: (2025-01-01) -
Time, location and function of hypoxia-inducible factors are critical to therapeutic tumour response
by: Laure Marignol, et al.
Published: (2024-07-01) -
Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1α
by: Xiawa Mao, et al.
Published: (2021-01-01)